Analysts’ Viewpoint on Global Clinical Decision Support System Market Scenario
Computerized clinical decision support systems, or CDSS, represent a paradigm shift in healthcare today. CDSS is used to assist physicians in their complex decision-making processes. It is aimed at improving healthcare delivery by enhancing medical decisions with targeted clinical information, patient information, and other health-related information mainly facilitated by the increasing global adoption of electronic medical records with advanced capabilities. Hence, the clinical decision support system market is expected to witness growth during the forecast period. Implementation of an effective system management program and increase in technological advancements, such as software integration with electronic health records, are likely to further boost the growth of the clinical decision support system market.
Clinical decision support system is an administrative as well as clinical tool that helps in improving operational efficiency of healthcare practices. Hospitals and clinics are required to handle large volume of patient information both administrative as well as clinical information. In order to handle the large volume of data, medical professionals and front office staff are always in search of an effective way to record, store, and improve access to patient information in an efficient manner. A clinical decision support system aids medical professionals and patients to streamline the workflows of medical practices and improve overall operational efficiency as well as patient care.
Physician recommendation for updating systems with alert systems and new technological innovation by different key players are likely to accelerate the growth of the global clinical decision support system market. Technological advancements such as software integration with other electronic health records are projected to fuel the growth of the global clinical decision support system market.
Request a sample to get extensive insights into the Clinical Decision Support System Market
Rise in technological advancements in CDSS, high awareness among patients, and increase in investments in healthcare IT solutions accelerate the growth of the global clinical decision support system market. A surge in group medical practices has been observed in the U.S., which is expected to fuel the growth of the cloud based clinical decision support system in the country during the forecast period.
Technological advancements in CDSS are expected to propel the clinical decision support system market in Asia Pacific, Latin America, and Middle East & Africa during the forecast period.
The global clinical decision support system market has been segmented based on usage based, application, mode of advice, delivery model, end-user, and region. In terms of usage based, the global clinical decision support system market has been classified into knowledge-based systems, expert laboratory information systems, and machine learning systems.
knowledge-based systems segment dominates the global market. The large share and high growth of this segment can be attributed to several beneficial functionalities of knowledge-based CDSS, such as helping clinicians with knowledge-based reasoning to make clinical decisions in the face of uncertainties. In 2020, the knowledge-based CDSS segment accounted for the largest share of 61% of the market. This segment is also estimated to register the highest CAGR of 9.2% during the forecast period.
There has been an increase in support in the development of innovative clinical decision support systems; for instance, Boston Children’s Hospital launched a clinical decision support innovation Challenge in which the winner receives rewards in the form of direct costs (around US$ 50,000), strategic project management support. and R&D software development support. Moreover, rise in collaboration of hospitals and clinics with healthcare IT firms and increasing incorporation of machine learning algorithms & AI methods will further support the CDSS Market.
Request a custom report on Clinical Decision Support System Market
Traditionally, on-premises and web-based clinical decision support systems were most commonly used in dental practices. On-premises software is associated with purchase of expensive servers and other hardware for data storage and backups. The software is priced on perpetual license model and is highly priced. Cloud-based clinical decision support system enables a user to host clinical applications, allows health information exchange, and data backup & recovery features. These cloud-based clinical decision support systems address specific challenges faced by the multi-location physician group practices as well as for solo practitioners. The cloud-based clinical decision support system facilitates easy recording, storage, and accessibility, and integration and retrieval of both clinical as well as non-clinical data from any point of location with an Internet connection.
In terms of region, the global clinical decision support system market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period, accounting for 40% share by 2031. The segment is anticipated to reach US$ 892.66 Mn by 2031.
The U.S. dominated the market in North America due to factors such as technologically advanced research & treatment platforms for diagnosis of chronic diseases, availability of a large number of reimbursement policies, well-established healthcare infrastructure, and increase in development of IT healthcare organizations. Rise in government initiatives and laws regarding usage of devices, and increase in population to drive the clinical decision support system market in the region.
Asia Pacific is projected to be the most attractive market for clinical decision support systems during the forecast period. The market in the region is anticipated to grow at a high CAGR of 10% during the forecast period due to rise in focus of market players on expanding their presence in the region to leverage the growth opportunities.
Improvement in healthcare infrastructure and commercialization of electronic health record (HER) in hospitals & clinics, high digital healthcare IT budgets provided by society as funds for IT development, and government initiatives to promote digital healthcare facilities contributed to the leading share of these regions.
Key players operating in the global clinical decision support system market include Allscripts Healthcare Solutions, Inc., First Databank, Inc., Truven Health Analytics, Cerner, Philips Healthcare, Siemens Healthcare, Optum, Inc. (UnitedHealth Group), GE Healthcare, and Epic Systems Corporation, Inc.
Each of these players has been profiled in the clinical decision support system market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 (Base Year) |
US$ 1.2 Bn |
|
Market Forecast Value in 2031 |
US$ 2.3 Bn |
|
Growth Rate (CAGR) |
8.8% |
|
Forecast Period |
2022–2031 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
|
Format |
Electronic (PDF) |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The clinical decision support system market was valued at US$ 1.2 Bn in 2021.
The clinical decision support system market is projected to cross over US$ 2.3 Bn by 2031.
The clinical decision support system market grew at a CAGR of 8% from 2017 to 2021.
The clinical decision support system market is anticipated to grow at a CAGR of 8.8% from 2022 to 2031.
Prominent players in the clinical decision support system market are Allscripts Healthcare Solutions, Inc., First Databank, Inc., Truven Health Analytics, Cerner, Philips Healthcare, Siemens Healthcare, Optum, Inc. (UnitedHealth Group), GE Healthcare, and Epic Systems Corporation, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Clinical Decision Support System Market
4. Market Overview
4.1. Introduction
4.1.1. Usage Based Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Clinical Decision Support System Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Clinical Decision Support System Market Analysis and Forecast. by Usage Based
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Usage Based, 2017–2031
6.3.1. Knowledge-based Systems
6.3.2. Expert Laboratory Information Systems
6.3.3. Machine Learning Systems
6.4. Market Attractiveness Analysis, by Usage Based
7. Global Clinical Decision Support System Market Analysis and Forecast. by Mode of Advice
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Mode of Advice, 2017–2031
7.3.1. Passive CDSS
7.3.2. Active CDSS
7.4. Market Attractiveness Analysis, by Mode of Advice
8. Global Clinical Decision Support System Market Analysis and Forecast. by Delivery Model
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Delivery Model, 2017–2031
8.3.1. On-premises
8.3.2. Web-based
8.3.3. Cloud-based
8.4. Market Attractiveness Analysis, by Delivery Model
9. Global Clinical Decision Support System Market Analysis and Forecast. by Application
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Drug Databases
9.3.2. Care Plans
9.3.3. Diagnostic Decision Support
9.3.4. Disease Reference
9.3.5. Others
9.4. Market Attractiveness Analysis, by Application
10. Global Clinical Decision Support System Market Analysis and Forecast. by End-user
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Diagnostic Centers
10.3.3. Clinics
10.3.4. Others
10.4. Market Attractiveness Analysis, by End-user
11. Global Clinical Decision Support System Market Analysis and Forecast. by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Clinical Decision Support System Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Usage Based, 2017–2031
12.2.1. Knowledge-based Systems
12.2.2. Expert Laboratory Information Systems
12.2.3. Machine Learning Systems
12.3. Market Value Forecast, by Mode of Advice, 2017–2031
12.3.1. Passive CDSS
12.3.2. Active CDSS
12.4. Market Value Forecast, by Delivery Model, 2017–2031
12.4.1. On-premises
12.4.2. Web-based
12.4.3. Cloud-based
12.5. Market Value Forecast, by Application, 2017–2031
12.5.1. Drug Databases
12.5.2. Care Plans
12.5.3. Diagnostic Decision Support
12.5.4. Disease Reference
12.5.5. Others
12.6. Market Value Forecast, by End-user, 2017–2031
12.6.1. Hospitals
12.6.2. Diagnostic Centers
12.6.3. Clinics
12.6.4. Others
12.7. Market Value Forecast, by Country, 2017–2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Usage Based
12.8.2. By Mode of Advice
12.8.3. By Delivery Model
12.8.4. By Application
12.8.5. By End-user
12.8.6. By Country
13. Europe Clinical Decision Support System Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Usage Based, 2017–2031
13.2.1. Knowledge-based Systems
13.2.2. Expert Laboratory Information Systems
13.2.3. Machine Learning Systems
13.3. Market Value Forecast, by Mode of Advice, 2017–2031
13.3.1. Passive CDSS
13.3.2. Active CDSS
13.4. Market Value Forecast, by Delivery Model, 2017–2031
13.4.1. On-premises
13.4.2. Web-based
13.4.3. Cloud-based
13.5. Market Value Forecast, by Application, 2017–2031
13.5.1. Drug Databases
13.5.2. Care Plans
13.5.3. Diagnostic Decision Support
13.5.4. Disease Reference
13.5.5. Others
13.6. Market Value Forecast, by End-user, 2017–2031
13.6.1. Hospitals
13.6.2. Diagnostic Centers
13.6.3. Clinics
13.6.4. Others
13.7. Market Value Forecast, by Country/Sub-region, 2017–2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Spain
13.7.5. Italy
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Usage Based
13.8.2. By Mode of Advice
13.8.3. By Delivery Model
13.8.4. By Application
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Clinical Decision Support System Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Usage Based, 2017–2031
14.2.1. Knowledge-based Systems
14.2.2. Expert Laboratory Information Systems
14.2.3. Machine Learning Systems
14.3. Market Value Forecast, by Mode of Advice, 2017–2031
14.3.1. Passive CDSS
14.3.2. Active CDSS
14.4. Market Value Forecast, by Delivery Model, 2017–2031
14.4.1. On-premises
14.4.2. Web-based
14.4.3. Cloud-based
14.5. Market Value Forecast, by Application, 2017–2031
14.5.1. Drug Databases
14.5.2. Care Plans
14.5.3. Diagnostic Decision Support
14.5.4. Disease Reference
14.5.5. Others
14.6. Market Value Forecast, by End-user, 2017–2031
14.6.1. Hospitals
14.6.2. Diagnostic Centers
14.6.3. Clinics
14.6.4. Others
14.7. Market Value Forecast, by Country/Sub-region, 2017–2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Usage Based
14.8.2. By Mode of Advice
14.8.3. By Delivery Model
14.8.4. By Application
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Clinical Decision Support System Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Usage Based, 2017–2031
15.2.1. Knowledge-based Systems
15.2.2. Expert Laboratory Information Systems
15.2.3. Machine Learning Systems
15.3. Market Value Forecast, by Mode of Advice, 2017–2031
15.3.1. Passive CDSS
15.3.2. Active CDSS
15.4. Market Value Forecast, by Delivery Model, 2017–2031
15.4.1. On-premises
15.4.2. Web-based
15.4.3. Cloud-based
15.5. Market Value Forecast, by Application, 2017–2031
15.5.1. Drug Databases
15.5.2. Care Plans
15.5.3. Diagnostic Decision Support
15.5.4. Disease Reference
15.5.5. Others
15.6. Market Value Forecast, by End-user, 2017–2031
15.6.1. Hospitals
15.6.2. Diagnostic Centers
15.6.3. Clinics
15.6.4. Others
15.7. Market Value Forecast, by Country/Sub-region, 2017–2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Usage Based
15.8.2. By Mode of Advice
15.8.3. By Delivery Model
15.8.4. By Application
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Clinical Decision Support System Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Usage Based, 2017–2031
16.2.1. Knowledge-based Systems
16.2.2. Expert Laboratory Information Systems
16.2.3. Machine Learning Systems
16.3. Market Value Forecast, by Mode of Advice, 2017–2031
16.3.1. Passive CDSS
16.3.2. Active CDSS
16.4. Market Value Forecast, by Delivery Model, 2017–2031
16.4.1. On-premises
16.4.2. Web-based
16.4.3. Cloud-based
16.5. Market Value Forecast, by Application, 2017–2031
16.5.1. Drug Databases
16.5.2. Care Plans
16.5.3. Diagnostic Decision Support
16.5.4. Disease Reference
16.5.5. Others
16.6. Market Value Forecast, by End-user, 2017–2031
16.6.1. Hospitals
16.6.2. Diagnostic Centers
16.6.3. Clinics
16.6.4. Others
16.7. Market Value Forecast, by Country/Sub-region, 2017–2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Usage Based
16.8.2. By Mode of Advice
16.8.3. By Delivery Model
16.8.4. By Application
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix
17.2. Market Share Analysis, by Company, 2021
17.3. Company Profiles
17.3.1. Allscripts Healthcare Solutions, Inc.
17.3.1.1. Company Overview (HQ, Business Segments, Employee)
17.3.1.2. Product Portfolio
17.3.1.3. SWOT Analysis
17.3.1.4. Strategic Overview
17.3.2. First Databank, Inc.
17.3.2.1. Company Overview (HQ, Business Segments, Employee)
17.3.2.2. Product Portfolio
17.3.2.3. SWOT Analysis
17.3.2.4. Strategic Overview
17.3.3. Truven Health Analytics
17.3.3.1. Company Overview (HQ, Business Segments, Employee)
17.3.3.2. Product Portfolio
17.3.3.3. SWOT Analysis
17.3.3.4. Strategic Overview
17.3.4. Cerner
17.3.4.1. Company Overview (HQ, Business Segments, Employee)
17.3.4.2. Product Portfolio
17.3.4.3. SWOT Analysis
17.3.4.4. Strategic Overview
17.3.5. Philips Healthcare
17.3.5.1. Company Overview (HQ, Business Segments, Employee)
17.3.5.2. Product Portfolio
17.3.5.3. SWOT Analysis
17.3.5.4. 17.3.5.4.Strategic Overview
17.3.6. Siemens Healthcare
17.3.6.1. Company Overview (HQ, Business Segments, Employee)
17.3.6.2. Product Portfolio
17.3.6.3. SWOT Analysis
17.3.6.4. Strategic Overview
17.3.7. Optum, Inc. (UnitedHealth Group)
17.3.7.1. Company Overview (HQ, Business Segments, Employee)
17.3.7.2. Product Portfolio
17.3.7.3. SWOT Analysis
17.3.7.4. Strategic Overview
17.3.8. GE Healthcare
17.3.8.1. Company Overview (HQ, Business Segments, Employee)
17.3.8.2. Product Portfolio
17.3.8.3. SWOT Analysis
17.3.8.4. Strategic Overview
17.3.9. Epic Systems Corporation Inc.
17.3.9.1. Company Overview (HQ, Business Segments, Employee)
17.3.9.2. Product Portfolio
17.3.9.3. SWOT Analysis
17.3.9.4. Strategic Overview
List of Tables
Table 01: Global Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage Based, 2017-2031
Table 02: Global Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031
Table 03: Global Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 04: Global Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031
Table 05: Global Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 06: Global Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 07: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 08: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage Based, 2017-2031
Table 09: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031
Table 10: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031
Table 11: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 12: North America Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage Based, 2017-2031
Table 15: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031
Table 16: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031
Table 17: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 18: Europe Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 19: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 20: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage Based, 2017-2031
Table 21: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031
Table 22: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031
Table 23: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 24: Asia Pacific Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 25: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 26: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage Based, 2017-2031
Table 27: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031
Table 28: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031
Table 29: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 30: Latin America Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 31: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 32: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage, 2017-2031
Table 33: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031
Table 34: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031
Table 35: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 36: Middle East & Africa Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Clinical Decision Support Systems Market Size (US$ Mn) Forecast, 2017-2031
Figure 03: Global Clinical Decision Support Systems Market Value Share, by Region, 2021
Figure 05: Global Clinical Decision Support Systems Market Value Share, by Application, 2021
Figure 02: Global Clinical Decision Support Systems Market Value Share, by Usage Based, 2021
Figure 04: Global Clinical Decision Support Systems Market Value Share, by End-user, 2021
Figure 03: Global Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2021
Figure 05: Global Clinical Decision Support Systems Market Value Share, by Delivery Model, 2021
Figure 08: Global Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031
Figure 09: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Knowledge-based Systems, 2017-2031
Figure 10: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Expert Laboratory Information Systems, 2017-2031
Figure 11: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Machine Learning Systems, 2017-2031
Figure 12: Global Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031
Figure 13: Global Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031
Figure 14: Global Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031
Figure 15: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Passive CDSS, 2017-2031
Figure 16: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Active CDSS, 2017-2031
Figure 17: Global Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031
Figure 18: Global Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031
Figure 20: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Care Plans, 2017-2031
Figure 19: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Databases, 2017-2031
Figure 21: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Decision Support, 2017-2031
Figure 22: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Disease Reference, 2017-2031
Figure 23: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2031
Figure 24: Global Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031
Figure 25: Global Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031
Figure 27: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Web-based, 2017-2031
Figure 26: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by On-premises, 2017-2031
Figure 28: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cloud-based, 2017-2031
Figure 29: Global Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031
Figure 30: Global Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031
Figure 32: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Centers, 2017-2031
Figure 31: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2031
Figure 33: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), Clinics, 2017-2031
Figure 34: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2017-2031
Figure 35: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2031
Figure 36: Global Clinical Decision Support Systems Market Value Share, by Region, 2017 and 2031
Figure 37: Global Clinical Decision Support Systems Market Attractiveness Analysis, by Region, 2017–2031
Figure 39: North America Clinical Decision Support Systems Market Value Share, by Country, 2017–2031
Figure 38: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
Figure 40: North America Clinical Decision Support Systems Market Attractiveness Analysis, by Country, 2017–2031
Figure 41: North America Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031
Figure 42: North America Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031
Figure 43: North America Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031
Figure 44: North America Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031
Figure 45: North America Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031
Figure 46: North America Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031
Figure 47: North America Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031
Figure 48: North America Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031
Figure 49: North America Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031
Figure 50: North America Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031
Figure 52: Europe Clinical Decision Support Systems Market Value Share, by Country/Sub-region, 2017–2031
Figure 51: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
Figure 53: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 54: Europe Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031
Figure 55: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031
Figure 56: Europe Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031
Figure 57: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031
Figure 58: Europe Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031
Figure 59: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031
Figure 60: Europe Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031
Figure 61: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031
Figure 62: Europe Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031
Figure 63: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031
Figure 65: Asia Pacific Clinical Decision Support Systems Market Value Share, by Country/Sub-region, 2017–2031
Figure 64: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
Figure 66: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 67: Asia Pacific Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031
Figure 68: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031
Figure 69: Asia Pacific Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031
Figure 70: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031
Figure 71: Asia Pacific Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031
Figure 72: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031
Figure 73: Asia Pacific Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031
Figure 74: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031
Figure 75: Asia Pacific Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031
Figure 76: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031
Figure 78: Latin America Clinical Decision Support Systems Market Value Share, by Country/Sub-region, 2017–2031
Figure 77: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 79: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 80: Latin America Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031
Figure 81: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031
Figure 82: Latin America Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031
Figure 83: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031
Figure 84: Latin America Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031
Figure 85: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031
Figure 86: Latin America Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031
Figure 87: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031
Figure 88: Latin America Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031
Figure 89: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031
Figure 91: Middle East & Africa Clinical Decision Support Systems Market Value Share, by Country/Sub-region, 2017–2031
Figure 90: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 92: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 93: Middle East & Africa Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031
Figure 94: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031
Figure 95: Middle East & Africa Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031
Figure 96: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031
Figure 97: Middle East & Africa Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031
Figure 98: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031
Figure 99: Middle East & Africa Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031
Figure 100: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031
Figure 101: Middle East & Africa Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031
Figure 102: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031
Figure 103: Global Clinical Decision Support Systems Market Share, by Company, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Clinical Decision Support System Market
